Clinical Trial Update: Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells Injection in Patients With Decompensated Hepatitis B Cirrhosis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating injections of human umbilical cord mesenchymal stem cells for decompensated hepatitis B cirrhosis and is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Hepatitis Cirrhosis

Drugs mentioned

• Human Umbilical Cord Mesenchymal Stem Cells

Snippet

Sponsor: Beijing Tuohua Weiye Biotechnology Co., Ltd. | Conditions: Decompensated Hepatitis B Cirrhosis | Phase 1, Phase 2 | Status: RECRUITING